Bruker announces agreement to acquire Chemspeed

Bruker Corporation has announced a definitive agreement for the acquisition of Chemspeed Technologies AG, a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions. Chemspeed is focused on modular automation and robotics solutions for chemical research, pharma drug formulation, materials research for cleantech and consumer applications.

The Chemspeed acquisition accelerates Bruker’s entry into laboratory automation, digitalisation and scientific software solutions. Chemspeed offers modular automation to enhance productivity in R&D and QC departments to achieve more in less time and without additional staff. Chemspeed complements Bruker’s vendor-agnostic platform SciY for software automation and digital transformation of R&D laboratories in the life science, biopharma and cleantech industries.

Strategically, Chemspeed’s automation solutions strengthens Bruker’s Project Accelerate 2.0 initiative ‘Assays, Software and Aftermarket’. The closing of the transaction is expected to occur in the first half of 2024, subject to regulatory reviews. Financial details of the transaction were not disclosed. In 2023, Chemspeed was profitable, generating revenues of over $50 million.

Specifically, Chemspeed offers a portfolio of flexible automation modules, ranging from bench-top workstations to integrated automated R&D workflows across many types of laboratory. Pictured above is the compact FLEX automation workstation. The company also offers compliance-ready workflow solutions to automate and digitalise R&D and QC in regulated environments, ensuring data integrity, traceability and quality.

Dr Rolf Gueller, the founder and CEO of Chemspeed, said: “Our team is excited to join Bruker to further boost automated and digitalized workflows for our customers. With decades of experience in automating R&D workflows, our modular solutions accelerate developments, allowing laboratory technicians and scientists to focus on their core competencies and creativity.” Advisory Board.

Dr Falko Busse, the President of the Bruker BioSpin Group, added: “Chemspeed’s scalable modularity and flexibility demonstrate what is achievable today in laboratory automation to customise workflows, integrate automation layers with efficient workflow and data management. We are excited to welcome the experienced team of Chemspeed to Bruker.”


Latest Issues